Hot pre-market trades in US stocks: Tharimmune up 10.22% pre-market; BUUU down 9.66% pre-market

Pre-market Hot Trades in US Stocks

Tharimmune is up 10.22% in pre-market trading. Based on recent news,

1. On January 31, despite Tharimmune currently being rated as a sell among analysts, some top analysts believe there are five other stocks that are more worthy of investment. This news may have sparked market interest in Tharimmune, leading to the rise in stock price.

2. On January 30, the shareholders' meeting approved all six proposals, including the election of directors, stock issuance related to warrants and private placements, and an increase in the equity incentive plan. The passage of these resolutions may have enhanced investor confidence in the company's future development, driving the stock price up. Recently, there has been increased market attention on the biotechnology sector.

BUUU is down 9.66% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

Top Gainers in Pre-market US Stocks

China Su Xuan Tang Pharmaceutical is up 156.77% in pre-market trading. Based on recent key news:

1. On January 30, China Su Xuan Tang Pharmaceutical announced a 1-for-150 stock consolidation. This move will reduce its Class A common shares to approximately 957,960 shares and continue trading on NASDAQ. This news has attracted market attention, leading to significant stock price fluctuations.

2. On January 31, following the announcement of the stock consolidation, the stock price of China Su Xuan Tang Pharmaceutical experienced a decline. Investors expressed concerns about the post-consolidation stock price performance, leading to price volatility.

3. There has been no other significant news recently. The market has reacted strongly to the stock consolidation, intensifying volatility.

VenHub Global is up 128.82% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

Darkiris is up 87.39% in pre-market trading. Based on recent key news:

1. On January 30, Darkiris reported a 27.3% revenue growth for the fiscal year 2025, reaching $10.08 million. This financial report indicates enhanced profitability for the company, driving the stock price significantly up. Source: GlobeNewswire

2. On January 29, the market expressed optimism about Darkiris's financial health, with shareholder equity increasing to $6.78 million, boosting investor confidence. Source: GlobeNewswire

3. On January 28, analysts gave a positive assessment of Darkiris's future growth potential, expecting its market share to further expand, stimulating the stock price increase. Source: GlobeNewswire The technology sector has recently performed strongly, with significant capital inflows